Cellebrite DI Ltd. (CLBT) Stock Overview
Explore Cellebrite DI Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Cellebrite DI Ltd. (CLBT)
Key Financials
Key Financials
Market Cap
2.8B
P/E Ratio
48.10
EPS (TTM)
$0.39
ROE
0.12%
CLBT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Cellebrite DI Ltd. (NASDAQ: CLBT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cellebrite DI Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CLBT on the NASDAQ shows an RSI of 34.36, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $13.80 for the NASDAQ listing.
Key metrics behind Cellebrite DI Ltd.'s NASDAQ-traded stock include a P/E ratio of 48.10 and a market capitalization of 2.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CLBT on the NASDAQ.